Triple
T23186584
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George D. Yancopoulos |
E579607
|
entity |
| Predicate | notableAchievement |
P477
|
FINISHED |
| Object | helped establish Regeneron as a major biotechnology company |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: helped establish Regeneron as a major biotechnology company | Statement: [George D. Yancopoulos, notableAchievement, helped establish Regeneron as a major biotechnology company]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: helped establish Regeneron as a major biotechnology company Context triple: [George D. Yancopoulos, notableAchievement, helped establish Regeneron as a major biotechnology company]
-
A.
Regeneron Pharmaceuticals
chosen
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Biotechnology Innovation Organization
The Biotechnology Innovation Organization is a major global trade association representing biotechnology companies, academic institutions, and related organizations, advocating for policies and innovation that advance healthcare, agriculture, and industrial biotech.
-
C.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
D.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
E.
Hargreave-Rasch Biotechnologies
Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245ff8000819090d12008805315b7 |
completed | April 17, 2026, 2:38 p.m. |
| NER | Named-entity recognition | batch_69f18fd3aaa08190b9cf7afe4ee5a38d |
completed | April 29, 2026, 4:57 a.m. |
Created at: April 17, 2026, 4:05 p.m.